Authors:
Brossart, P
Schneider, A
Dill, P
Schammann, T
Grunebach, F
Wirths, S
Kanz, L
Buhring, HJ
Brugger, W
Citation: P. Brossart et al., The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-Lymphocytes, CANCER RES, 61(18), 2001, pp. 6846-6850
Authors:
Kleihauer, A
Grigoleit, U
Hebart, H
Moris, A
Brossart, P
Muhm, A
Stevanovic, S
Rammensee, HG
Sinzger, C
Riegler, S
Jahn, G
Kanz, L
Einsele, H
Citation: A. Kleihauer et al., Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells, BR J HAEM, 113(1), 2001, pp. 231-239
Authors:
Seiffert, M
Brossart, P
Cant, C
Cella, M
Colonna, M
Brugger, W
Kanz, L
Ullrich, A
Buhring, HJ
Citation: M. Seiffert et al., Signal-regulatory protein alpha (SIRP alpha) but not SIRP beta is involvedin T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells, BLOOD, 97(9), 2001, pp. 2741-2749
Authors:
Kugler, A
Stuhler, G
Walden, P
Zoller, G
Zobywalski, A
Brossart, P
Trefzer, U
Ullrich, S
Muller, CA
Becker, V
Gross, AJ
Hemmerlein, B
Kanz, L
Muller, GA
Ringert, RH
Citation: A. Kugler et al., Regression of human metastatic renal cell carcinoma after vaccination withtumor cell-dendritic cell hybrids, NAT MED, 6(3), 2000, pp. 332-336
Authors:
Riegler, S
Hebart, H
Einsele, H
Brossart, P
Jahn, G
Sinzger, C
Citation: S. Riegler et al., Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus, J GEN VIROL, 81, 2000, pp. 393-399
Authors:
Brossart, P
Zobywalski, A
Grunebach, F
Behnke, L
Stuhler, G
Reichardt, VL
Kanz, L
Brugger, W
Citation: P. Brossart et al., Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells, CANCER RES, 60(16), 2000, pp. 4485-4492
Authors:
Brossart, P
Wirths, S
Stuhler, G
Reichardt, VL
Kanz, L
Brugger, W
Citation: P. Brossart et al., Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells, BLOOD, 96(9), 2000, pp. 3102-3108
Authors:
Kanz, L
Brossart, P
Stuhler, G
Reichardt, V
Kleihauer, A
Scheding, S
Stevanovic, S
Einsele, H
Rammensee, HG
Brugger, W
Citation: L. Kanz et al., Pre-clinical and early clinical experience using dendritic cells to treat human malignancy, HEM CELL TH, 41(2), 1999, pp. 56-57
Authors:
Brugger, W
Buhring, HJ
Grunebach, F
Vogel, W
Kaul, S
Muller, R
Brummendorf, TH
Ziegler, BL
Rappold, I
Brossart, P
Scheding, S
Kanz, L
Citation: W. Brugger et al., Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells, J CL ONCOL, 17(5), 1999, pp. 1535-1544
Authors:
Stuhler, G
Zobywalski, A
Grunebach, F
Brossart, P
Reichardt, VL
Barth, H
Stevanovic, S
Brugger, W
Kanz, L
Schlossman, SF
Citation: G. Stuhler et al., Immune regulatory loops determine productive interactions within human T lymphocyte dendritic cell clusters, P NAS US, 96(4), 1999, pp. 1532-1535
Authors:
Brossart, P
Spahlinger, B
Grunebach, F
Stuhler, G
Reichardt, VL
Kanz, L
Brugger, W
Citation: P. Brossart et al., Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation, BLOOD, 94(12), 1999, pp. 4374-4376
Authors:
Brossart, P
Heinrich, KS
Stuhler, G
Behnke, L
Reichardt, VL
Stevanovic, S
Muhm, A
Rammensee, HG
Kanz, L
Brugger, W
Citation: P. Brossart et al., Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies, BLOOD, 93(12), 1999, pp. 4309-4317
Authors:
Flad, T
Spengler, B
Kalbacher, H
Brossart, P
Baier, D
Kaufmann, R
Bold, P
Metzger, S
Bluggel, M
Meyer, HE
Kurz, B
Muller, CA
Citation: T. Flad et al., Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method, CANCER RES, 58(24), 1998, pp. 5803-5811